Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 48Gastrointestinal Stromal Tumors 26Leukemia 20Leukemia, Myeloid, Chronic-Phase 15Philadelphia Chromosome 9Leukemia, Myeloid 8Bone Marrow Diseases 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Hematologic Neoplasms 4Hematologic Diseases 4Blast Crisis 4Myeloproliferative Disorders 3Leukemia, Myeloid, Acute 3Hypereosinophilic Syndrome 3Glioblastoma 3Digestive System Neoplasms 3Bronchiolitis Obliterans Syndrome 3Recurrence 2Prostatic Neoplasms 2Neurofibrosarcoma 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Multiple Myeloma 2Leukemia, Myeloid, Accelerated Phase 2Dermatofibrosarcoma 2Chordoma 2Brain Neoplasms 2Adenocarcinoma 2Urogenital Neoplasms 1

Interventions

Mitomycin 3Abiraterone Acetate 3motexafin gadolinium 2abiraterone 2Suspensions 2Sunitinib 2Powders 2Paclitaxel 2Gemcitabine 2Drug Therapy 2Docetaxel 2vinflunine 1valrubicin 1temsirolimus 1sipuleucel-T 1pembrolizumab 1palbociclib 1onapristone 1olaparib 1niraparib 1luprolide acetate gel depot 1gallium 68 PSMA-11 1enfortumab vedotin 1darolutamide 1atezolizumab 1apalutamide 1abemaciclib 1Watchful Waiting 1Transurethral Resection of Prostate 1Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Urogenital Neoplasms × Imatinib Mesylate × Clear all
NCT01316458 2017-06-01

Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

Novartis

Phase 2 Completed
51 enrolled
Genitourinary

Abdominal Neoplasms, Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡